Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology

Stock Information for Nutriband Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Nutriband Inc.

Nutriband and Kindeva Complete Commercial Manufacturing Process Scale-up for Aversa(TM) Fentanyl Abuse Deterrent Fentanyl Patch
Nutriband Inc. to present at the 2025 Noble Capital Markets Virtual Equity Conference
Nutriband Inc. Quarterly Report Highlights Record Revenue for Q1, 2025 up 63% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Gareth Sheridan, CEO of Nutriband Inc.
Nutriband CEO Publishes Letter to Shareholders
Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology
UPDATE - Nutriband Signs Associate Partnership with Charlotte FC
Nutriband Signs Partnership Agreement with Charlotte FC

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.